Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
US9862730B2 · kind B2 · utility
4Cited by
1References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 24, 2013 |
| Grant date | Jan 9, 2018 |
| Priority date | — |
| Expiry date | Jan 22, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides imidazothiadiazole compounds of Formula (I) wherein A, B, D, Rx, R1, R2, R3, X1, X2 and s are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.